Bay Capital Plc AI Stock Analysis
Want to see GB:BAY full AI Analyst Report?
Bay Capital Plc (BAY) AI Stock Analysis
Bay Capital Plc
(LSE:BAY)
Primarily impacted by weak financials from lack of operations and cash burn, offset by strong technical momentum in the stock price.
Bay Capital Plc (BAY) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 10.68M
- Dividend Yield
- ―
- Average Volume (3M)
- 153.69K
- Price to Earnings (P/E)
- -29.9
- Beta (1Y)
- 0.37
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- UK
- Employees
- 2
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Shell Companies
Bay Capital Plc Business Overview & Revenue Model
Company Description
Bay Capital Plc, established in 2021 and headquartered in Saint Helier, Jersey, currently operates without significant active business engagements. Its primary objective is to seek out and capitalize on investment and acquisition prospects. The compa...
Bay Capital Plc Financial Statement Overview
Summary
Weak due to zero revenue, persistent net losses, and cash burn, though supported by zero debt and positive but declining equity.
Income Statement
15Very NegativeBalance Sheet
45NeutralCash Flow
20Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | -338.70K | -60.03K | 452 | -254.00K | 112 |
| Net Income | -352 | -323.25K | -550 | -1.31M | -251.00K | -412.00K |
Balance Sheet | ||||||
| Total Assets | 4.16M | 4.35M | 4.67M | 6.08M | 6.47M | 6.72M |
| Cash, Cash Equivalents and Short-Term Investments | 4.15M | 4.34M | 4.66M | 6.07M | 6.46M | 6.72M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 52.03K | 85.46K | 91.67K | 958.67K | 53.52K | 69.64K |
| Stockholders Equity | 4.11M | 4.26M | 4.58M | 5.12M | 6.41M | 6.65M |
Cash Flow | ||||||
| Free Cash Flow | -336.14K | -334.21K | -1.44M | -441.38K | -262.17K | -318 |
| Operating Cash Flow | -336.14K | -334.21K | -1.44M | -441.38K | -264.48K | -318 |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 12.41K | 12.70K | 36.90K | 50.77K | 2,314 | 9,278 |
Bay Capital Plc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BAY, the sentiment is Positive. The current price of 15.25 is equal to the 20-day moving average (MA) of 15.25, above the 50-day MA of 13.93, and above the 200-day MA of 9.48, indicating a neutral trend. The MACD of 0.35 indicates Positive momentum. The RSI at 69.00 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:BAY.
Bay Capital Plc Peers Comparison
Overall Rating
GB:BAY54Neutral
GB:ALK42Neutral
GB:BRS42Neutral
GB:AC841Neutral
GB:MII40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 54Neutral | GBP 10.68M | -29.90 | >-0.01% | ― | ― | ― | |
| 42Neutral | GBP 27.35M | -6.40 | 696.85% | ― | ― | -24.61% | |
| 42Neutral | GBP 2.08M | -3.37 | -1.37% | ― | ― | ― | |
| 41Neutral | GBP 387.05M | -1.18 | 159.98% | ― | ― | -788.78% | |
| 40Underperform | GBP 481.80K | -1.38 | -80.63% | ― | ― | ― |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:BAY | Bay Capital Plc | 15.25 | 10.75 | 238.89% | |
| GB:AC8 | Acceler8 Ventures Plc | 51.00 | 31.20 | 157.63% | |
| GB:ALK | Alkemy Capital Investments Plc | 241.50 | -42.00 | -14.81% | |
| GB:BRS | Beacon Rise Holdings PLC | 160.00 | 0.00 | 0.00% | |
| GB:MII | Milton Capital PLC | 0.22 | -0.16 | -42.11% |
Bay Capital Plc Corporate Events
Bay Capital Moves to Acquire Biosimilars Developer Plenty Biologics in £40m All-Share Deal
PositiveBay Capital Plc has agreed heads of terms to acquire biosimilars specialist Plenty Biologics Limited in an all-share deal valuing the target at £40 million on a debt-free basis, with 266.7 million new shares to be issued at 15 pence and principal sel...
Bay Capital posts small interim loss as it pursues high-growth acquisitions
NeutralBay Capital Plc reported an unaudited loss after tax of £159,082 for the six months to 30 June 2026, slightly wider than the prior year period, as operating and acquisition-related expenses rose while loss per share remained at 0.2 pence. The company...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
